Hepatitis C and Liver Transplantation in the HIV Co-infected Patients
作者： Teresa Maria Antonini , Jean Charles Duclos-Vallée , Didier Samuel
DOI: 10.1007/978-1-4614-8438-7_5
关键词:
摘要: The introduction of antiretroviral therapies (cART) has improved the survival patients infected with human immunodeficiency virus (HIV). Because shared ways transmission, 30 % HIV-infected have hepatitis B (HBV) or C (HCV) co-infection; so, till date, liver disease is a major cause non-acquired syndrome (AIDS)-related deaths. Survival end-stage shorter than in non-HIV-infected patients. For this reason, transplantation (LT) must be evaluated after first episode decompensation. risk opportunistic LT low, while HCV recurrence central problem and affects post-transplant patients’ survival. Standard anti-HCV therapy pegylated interferon ribavirin resulted low response rate. This should change advent new drugs better antiviral activity. would allow viral control from time transplant will improve results HCV/HIV co-infected
springer.com
sci-hub.st 参考文章(47)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study JAMA Internal Medicine. ,vol. 166, pp. 1632- 1641 ,(2006) , 10.1001/ARCHINTE.166.15.1632
T. M. Antonini, M. Sebagh, A. M. Roque-Afonso, E. Teicher, B. Roche, R. Sobesky, A. Coilly, P. Vaghefi, R. Adam, D. Vittecoq, D. Castaing, D. Samuel, J.-C. Duclos-Vallée, Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation. American Journal of Transplantation. ,vol. 11, pp. 1686- 1695 ,(2011) , 10.1111/J.1600-6143.2011.03608.X
Margaret V. Ragni, Bijan Eghtesad, Kimberly W. Schlesinger, Igor Dvorchik, John J. Fung, Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transplantation. ,vol. 11, pp. 1425- 1430 ,(2005) , 10.1002/LT.20534
P. Stock, M. Roland, L. Carlson, C. Freise, R. Hirose, N. Terrault, L. Frassetto, T. Coates, J. Roberts, N. Ascher, Solid organ transplantation in HIV-positive patients. Transplantation proceedings. ,vol. 33, pp. 3646- 3648 ,(2001) , 10.1016/S0041-1345(01)02569-6
P Cacoub, D Sène, E Rosenthal, S Pol, None, Co-infection par le virus de l’immunodéficience humaine et le virus de l’hépatite C Gastroenterologie Clinique Et Biologique. ,vol. 32, ,(2008) , 10.1016/S0399-8320(08)73270-6
Deepak Joshi, John O'Grady, Doug Dieterich, Brian Gazzard, Kosh Agarwal, Increasing burden of liver disease in patients with HIV infection The Lancet. ,vol. 377, pp. 1198- 1209 ,(2011) , 10.1016/S0140-6736(10)62001-6
Dominique Salmon-Ceron, Charlotte Lewden, Philippe Morlat, Sibylle Bévilacqua, Eric Jougla, Fabrice Bonnet, Laurence Héripret, Dominique Costagliola, Thierry May, Geneviève Chêne, Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol Journal of Hepatology. ,vol. 42, pp. 799- 805 ,(2005) , 10.1016/J.JHEP.2005.01.022
Charlotte Lewden, Thierry May, Eric Rosenthal, None, Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). Journal of Acquired Immune Deficiency Syndromes. ,vol. 48, pp. 590- 598 ,(2008) , 10.1097/QAI.0B013E31817EFB54
Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, Marga van Zutven, Edward O'Mara, Hwa-Ping Feng, John Wagner, Joan Butterton, Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers Hepatology. ,vol. 56, pp. 1622- 1630 ,(2012) , 10.1002/HEP.25831
Mariagrazia Tateo, Anne-Marie Roque-Afonso, Teresa Maria Antonini, Fadia Medja, Anne Lombes, Claude Jardel, Elina Teicher, Mylène Sebagh, Bruno Roche, Denis Castaing, Didier Samuel, Jean-Charles Duclos-Vallee, Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS. ,vol. 23, pp. 1069- 1076 ,(2009) , 10.1097/QAD.0B013E32832C2A37